Published in J Endotoxin Res on January 01, 2007
Toll-like receptors as targets in chronic liver diseases. Gut (2009) 2.29
A calculated response: control of inflammation by the innate immune system. J Clin Invest (2008) 1.93
Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med (2010) 1.41
Innate and adaptive immune responses to cell death. Immunol Rev (2011) 1.40
The Role of TLR2 in Infection and Immunity. Front Immunol (2012) 1.28
Toll-like receptors, wound healing, and carcinogenesis. J Mol Med (Berl) (2008) 1.27
Toll-like receptors in Alzheimer's disease. Curr Top Microbiol Immunol (2009) 1.27
Trauma equals danger--damage control by the immune system. J Leukoc Biol (2012) 1.15
Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis (2010) 1.13
The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides. Int Immunopharmacol (2008) 1.11
Toll-like receptors in ocular surface disease. Exp Eye Res (2010) 1.05
The critical role of toll-like receptors - From microbial recognition to autoimmunity: A comprehensive review. Autoimmun Rev (2015) 0.97
Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice. Anesthesiology (2010) 0.96
The contribution of direct TLR signaling to T cell responses. Immunol Res (2009) 0.94
Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins. Microb Cell Fact (2015) 0.90
Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens (2009) 0.90
Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant (2008) 0.86
Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma. Clin Exp Immunol (2012) 0.85
Toll-like receptors in urothelial cells--targets for cancer immunotherapy. Nat Rev Urol (2013) 0.85
Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. Br J Pharmacol (2011) 0.83
Immunostimulating activity by polysaccharides isolated from fruiting body of Inonotus obliquus. Mol Cells (2010) 0.81
Endotoxemia-menace, marker, or mistake? J Leukoc Biol (2016) 0.80
Innate pathways of immune activation in transplantation. J Transplant (2010) 0.80
The danger model: questioning an unconvincing theory. Immunol Cell Biol (2015) 0.78
The synthetic parasite-derived peptide GK1 increases survival in a preclinical mouse melanoma model. Cancer Biother Radiopharm (2013) 0.77
TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo. J Inflamm (Lond) (2013) 0.77
TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations. Int J Mol Sci (2016) 0.75
Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation. Mediators Inflamm (2017) 0.75
Endogenous ligands of Toll-like receptors. J Leukoc Biol (2004) 3.53
Heat shock proteins and immune system. J Leukoc Biol (2009) 2.54
Cytokine function of heat shock proteins. Am J Physiol Cell Physiol (2004) 1.89
Heat shock protein and innate immunity. Cell Mol Immunol (2004) 1.33
Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res (2010) 0.93
Assessing the quality of human research protection programs: the experience at the Department of Veterans Affairs. IRB (2010) 0.87
TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin. Am J Physiol Lung Cell Mol Physiol (2002) 0.80
Induction of cytokines by heat shock proteins and concanavalin A in murine splenocytes. Cytokine (2005) 0.79